form8-k.htm
 
 


 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
January 11, 2012
Date of Report
 
Novo Energies Corporation
(Exact name of registrant as specified in its charter)
 
Florida
 
000-53723
 
65-1102237
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.) 
 
 
Europa Place d'Armes, 750 Côte de Place d'Armes
Suite 64, Montréal Qc H2Y 2X8
Canada
 
 
 (Address of principal executive offices)
 
 
(514) 840-3697
  Registrant's telephone number, including area code
 
 
(Former name or former address, if changed since last report)
 
 Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[    ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[    ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[    ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[    ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 


 
 

 

Item 1.01                      Entry into Material Definitive Agreement

We have entered into an oral agreement with our Chief Executive officer and a consultant pursuant to which upon the later of (i) the first payment of funds to us from a capital raise in an amount of up to $5,000,000 and (ii) the first payment of fees due to Immunovative Therapies Ltd. under a License Agreement that we entered into with Immunovative Therapies Ltd. on December 12, 2011, each of our Chief Executive officer and the consultant will be granted options to purchase up to 5,000,000 shares of our common stock at a purchase price of $0.10.  The options will vest upon granting and will be exercisable for a period of ten years.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
 
 NOVO ENERGIES CORPORATION
 
By: /s/ Antonio Treminio
Antonio Treminio
Chief Executive Officer
January 11, 2012